Hepatocellular carcinoma: the search for innovative adjuvant therapies.
Yen
Yun
Y
City of Hope Comprehensive Cancer Center, Duarte, California, USA.
Zhou
Wendi
W
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001557:Benzenesulfonates / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D018572:Disease-Free Survival; D006801:Humans; D016219:Immunotherapy, Adoptive; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000601:surgery; D016031:Liver Transplantation; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D009366:Neoplasm Seeding; D009367:Neoplasm Staging; D009536:Niacinamide / Q000031:analogs & derivatives; D018579:Patient Selection; D010671:Phenylurea Compounds; D011725:Pyridines / Q000627:therapeutic use; D012307:Risk Factors; D000077157:Sorafenib
D000970:Antineoplastic Agents; D001557:Benzenesulfonates; D019496:Cancer Vaccines; D010671:Phenylurea Compounds; D011725:Pyridines; D009536:Niacinamide; D000077157:Sorafenib